Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Change in Cash (2016 - 2025)

Historic Change in Cash for iBio (IBIO) over the last 17 years, with Q4 2025 value amounting to $561000.0.

  • iBio's Change in Cash rose 11394.48% to $561000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $21.7 million, marking a year-over-year increase of 58162.37%. This contributed to the annual value of -$5.6 million for FY2025, which is 18228.16% down from last year.
  • According to the latest figures from Q4 2025, iBio's Change in Cash is $561000.0, which was up 11394.48% from $19.5 million recorded in Q3 2025.
  • Over the past 5 years, iBio's Change in Cash peaked at $19.5 million during Q3 2025, and registered a low of -$17.7 million during Q4 2021.
  • For the 5-year period, iBio's Change in Cash averaged around -$3.1 million, with its median value being -$3.0 million (2023).
  • Its Change in Cash has fluctuated over the past 5 years, first tumbled by 47389.44% in 2024, then soared by 71779.39% in 2025.
  • Quarter analysis of 5 years shows iBio's Change in Cash stood at -$17.7 million in 2021, then skyrocketed by 32.48% to -$11.9 million in 2022, then surged by 94.13% to -$701000.0 in 2023, then tumbled by 473.89% to -$4.0 million in 2024, then skyrocketed by 113.94% to $561000.0 in 2025.
  • Its Change in Cash stands at $561000.0 for Q4 2025, versus $19.5 million for Q3 2025 and $3.6 million for Q2 2025.